CJC-1295 With DAC Long-Acting Growth Hormone Releasing Research Peptide
- Createtime： 2026-07-08
- Updatetime： 2026-06-30
Product Details
| One box |
10vials
|
| useage |
For sustained GH secretion, muscle anabolism and metabolic aging research
|
| deliveryInfo |
|
| appearance |
White lyophilized powder
|
| aliasen |
|
| supplyCapacity |
100G/Day
|
| harbor |
Hong Kong
|
| minorder |
1G
|
| Payment method |
Alibaba, PayPal, USDT, bank card, Western Union remittance
|
| Delivery date |
10 days
|
| Whatsapp |
+86 155 1138 8892
|
Name: CJC-1295 With DAC
Alias: Long-acting CJC-1295 / Drug Affinity Complex Modified GRF 1-29
CAS Registry number: 446262-90-4
Sequence:
H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH? (DAC modified)
Molecular Formula: C???H???N??O??S
Molecular Weight: 3647.15 Da
Purity: ≥99% (by HPLC)
Appearance: White lyophilized powder
Packing: 10 vials/box (10mg total per vial)
Product Group: Long-acting growth hormone releasing hormone analog peptide
Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.
Brief Introduction:
CJC-1295 With DAC is a long-acting synthetic GHRH analog exclusively for laboratory research. Modified with Drug Affinity Complex, it binds to serum albumin effectively, greatly extending peptide half-life and maintaining stable long-term growth hormone releasing activity. It continuously activates pituitary GHRH receptors to promote steady endogenous GH secretion, and produces significant synergistic effects when combined with GHRP series peptides. It regulates long-term muscle anabolism, fat metabolism and endocrine balance, widely applied in long-term metabolic regulation, endocrine aging and body composition research.
Main Research Applications:
Long-acting endocrine regulation research: Used in cell and animal models to study sustained GH release and long-term endocrine homeostasis mechanisms.
Muscle growth & fat metabolism research: Suitable for exploring long-cycle lean muscle accumulation and continuous adipose lipolysis pathways.
Peptide synergistic effect research: Applied to investigate long-acting GH elevation effects combined with GHRP-2, GHRP-6 and Ipamorelin.
Endocrine anti-aging research: For comparative analysis of long-term hormone deficiency intervention and metabolic aging improvement.
Chronic metabolic regulation research: Study the sustained regulatory impact on IGF-1 level and whole-body energy metabolism.
Note:
This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.
